ProCE Banner Activity

Transforming the Care of Patients With Non-Small-Cell Lung Cancer: Optimizing Immune Checkpoint Inhibitor Therapy


To access the downloadable PowerPoint slide set on immune checkpoint inhibitors in NSCLC, please click the download button.

Released: April 22, 2022

Expiration: April 21, 2023

No longer available for credit.



This activity is supported by educational grants from Bristol Myers Squibb; Genentech, a member of the Roche Group; Merck Sharp & Dohme Corp.; and Regeneron Pharmaceuticals, Inc and Sanofi.


Bristol Myers Squibb

Genentech, a member of the Roche Group

Regeneron Pharmaceuticals, Inc


Additional Information

Program Medium

This program has been made available online.